Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Absci (ABSI) Cash & Equivalents (2020 - 2025)

Absci (ABSI) has disclosed Cash & Equivalents for 6 consecutive years, with $20.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents fell 51.41% to $20.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.0 million through Dec 2025, down 51.41% year-over-year, with the annual reading at $20.0 million for FY2025, 51.41% down from the prior year.
  • Cash & Equivalents hit $20.0 million in Q4 2025 for Absci, up from $9.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $279.3 million in Q3 2021 to a low of $9.5 million in Q3 2025.
  • Historically, Cash & Equivalents has averaged $79.4 million across 5 years, with a median of $50.0 million in 2022.
  • Biggest five-year swings in Cash & Equivalents: plummeted 94.95% in 2023 and later skyrocketed 415.65% in 2024.
  • Year by year, Cash & Equivalents stood at $252.6 million in 2021, then plummeted by 76.26% to $60.0 million in 2022, then increased by 20.69% to $72.4 million in 2023, then tumbled by 43.05% to $41.2 million in 2024, then tumbled by 51.41% to $20.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for ABSI at $20.0 million in Q4 2025, $9.5 million in Q3 2025, and $38.0 million in Q2 2025.